Mitral valve prolapse: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 117: Line 117:
===Left Ventriculography===
===Left Ventriculography===


<googlevideo>1357398178641849422&hl=en</googlevideo>
{{#ev:googlevideo|1357398178641849422}}


==Mitral valve prolapse syndrome==
==Mitral valve prolapse syndrome==

Revision as of 15:26, 3 October 2011

For patient information click here

Mitral valve prolapse
Mitral Valve Prolapse: Gross natural color view from left atrium showing prolapsed anterior leaflet into atrium Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10 I34.1
ICD-9 394.0, 424.0
OMIM 157700
DiseasesDB 8303
MedlinePlus 000180
MeSH D008945

WikiDoc Resources for Mitral valve prolapse

Articles

Most recent articles on Mitral valve prolapse

Most cited articles on Mitral valve prolapse

Review articles on Mitral valve prolapse

Articles on Mitral valve prolapse in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mitral valve prolapse

Images of Mitral valve prolapse

Photos of Mitral valve prolapse

Podcasts & MP3s on Mitral valve prolapse

Videos on Mitral valve prolapse

Evidence Based Medicine

Cochrane Collaboration on Mitral valve prolapse

Bandolier on Mitral valve prolapse

TRIP on Mitral valve prolapse

Clinical Trials

Ongoing Trials on Mitral valve prolapse at Clinical Trials.gov

Trial results on Mitral valve prolapse

Clinical Trials on Mitral valve prolapse at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mitral valve prolapse

NICE Guidance on Mitral valve prolapse

NHS PRODIGY Guidance

FDA on Mitral valve prolapse

CDC on Mitral valve prolapse

Books

Books on Mitral valve prolapse

News

Mitral valve prolapse in the news

Be alerted to news on Mitral valve prolapse

News trends on Mitral valve prolapse

Commentary

Blogs on Mitral valve prolapse

Definitions

Definitions of Mitral valve prolapse

Patient Resources / Community

Patient resources on Mitral valve prolapse

Discussion groups on Mitral valve prolapse

Patient Handouts on Mitral valve prolapse

Directions to Hospitals Treating Mitral valve prolapse

Risk calculators and risk factors for Mitral valve prolapse

Healthcare Provider Resources

Symptoms of Mitral valve prolapse

Causes & Risk Factors for Mitral valve prolapse

Diagnostic studies for Mitral valve prolapse

Treatment of Mitral valve prolapse

Continuing Medical Education (CME)

CME Programs on Mitral valve prolapse

International

Mitral valve prolapse en Espanol

Mitral valve prolapse en Francais

Business

Mitral valve prolapse in the Marketplace

Patents on Mitral valve prolapse

Experimental / Informatics

List of terms related to Mitral valve prolapse

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Mitral valve prolapse (MVP) is a valvular heart disease characterized by the displacement of an abnormally thickened mitral valve leaflet into the left atrium during systole. In its nonclassic form, MVP carries a low risk of complications. In severe cases of classic MVP, complications include mitral regurgitation and infective endocarditis.

The mitral valve, so named because of its resemblance to a bishop's miter, is the heart valve that prevents the backflow of blood from the left ventricle into the left atrium. It is composed of two leaflets (one anterior, one posterior) that close when the left ventricle contracts.[1]

Each leaflet is composed of three layers of tissue: the atrialis, fibrosa, and spongiosa. Patients with classic mitral valve prolapse have excess connective tissue that thickens the spongiosa and separates collagen bundles in the fibrosa. This is due to an excess of dermatan sulfate, a glycosaminoglycan. This weakens the leaflets and adjacent tissue, resulting in increased leaflet area and elongation of the chordae tendineae. Elongation of the chordae may be associated with chordae rupture, and is commonly found in the chordae tendineae attached to the posterior leaflet. Advanced lesions — also commonly involving the posterior leaflet — lead to leaflet folding, inversion, and displacement toward the left atrium.

History

The term mitral valve prolapse was coined by J. Michael Criley in 1966 and gained acceptance over the other descriptor of "billowing" of the mitral valve, as originally described by JB Barlow.[2]. Barlow had postulated that mitral valve prolapse was due to an aneurysm of the mitral leaflet and Criley demonstrated that it was instead due to displacement of the leaflet that led to the condition.

For many years, mitral valve prolapse was a poorly understood anomaly associated with a wide variety of both related and seemingly unrelated signs and symptoms, including late systolic murmurs, inexplicable panic attacks, and polythelia (extra nipples). Recent studies suggest that these symptoms were incorrectly linked to MVP because the disorder was simply over-diagnosed at the time. Continuously-evolving criteria for diagnosis of MVP with echocardiography have made the diagnosis more rigorous and specific. As a result, there may have been many patients who would not currently be classified as having MVP who were included in original studies of the disorder and its prevalence. In fact, some modern studies report that as many as 55% of the population would be diagnosed with MVP if older, less specific criteria for the diagnosis of MVP, such as M-mode echocardiography—were applied today.

In recent years, new objective diagnostic criteria for MVP have been proposed based upon two- and three-dimensional echocardiography. The disorder has also been classified into a number of subtypes with respect to these echocardiographic criteria.

Subtypes

Prolapsed mitral valves are classified into several subtypes, based on leaflet thickness, concavity, and type of connection to the mitral annulus. Subtypes can be described as classic, nonclassic, symmetric, asymmetric, flail, or non-flail.

Note: all measurements below refer to adult patients and applying them to children may be misleading.

Classic versus nonclassic

Prolapse occurs when the mitral valve leaflets are displaced more than 2 mm above the mitral annulus high points. The condition can be further divided into classic and nonclassic subtypes based on the thickness of the mitral valve leaflets: up to 5 mm is considered nonclassic, while anything beyond 5 mm is considered classic MVP.

Symmetric versus asymmetric

Classic MVP may be subdivided into symmetric and asymmetric, referring to the point at which leaflet tips join the mitral annulus. In symmetric coaptation, leaflet tips meet at a common point on the annulus. Asymmetric coaptation is characterized by one leaflet being displaced toward the atrium with respect to the other. Patients with asymmetric prolapse are susceptible to severe deterioration of the mitral valve, with the possible rupture of the chordae tendineae and the development of a flail leaflet.

Flail versus non-flail

Asymmetric prolapse is further subdivided into flail and non-flail prolapse. Flail prolapse occurs when a leaflet tip turns outward, becoming concave toward the left atrium, causing the deterioration of the mitral valve. The severity of flail leaflet varies, ranging from tip eversion to chordal rupture. Dissociation of leaflet and chordae tendineae provides for unrestricted motion of the leaflet (hence "flail leaflet"). Thus patients with flail leaflets have a higher prevalence of mitral regurgitation than those with the non-flail subtype.

Diagnosis

Two- and three-dimensional echocardiography are valuable in the diagnosis of MVP as they allow visualization of the mitral leaflets relative to the mitral annulus. This allows measurement of the leaflet thickness and their displacement relative to the annulus. Thickening of the mitral leaflets >5 mm and leaflet displacement >2 mm indicates classic mitral valve prolapse.

Differential Diagnosis of Underlying Causes

  • Acquired
  • Congenital
  • Marfan's Syndrome
  • Myxomatous generation of the mitral valve
  • Papillary muscle infarction
  • Papillary muscle trauma

Prevalence

Prior to the development of rigorous criteria for the diagnosis and classification of mitral valve prolapse, as described above, the incidence of mitral valve prolapse in the general population varied significantly. Studies estimated the incidence of mitral valve prolapse at 5 to 15 percent or even higher.[3]

As part of the Framingham Heart Study, more modern estimates of the prevalence of mitral valve prolapse have been lower at 2.4%. There was a near-even split between classic and nonclassic MVP, with no significant age or sex discrimination.[4] Based on data gathered in the United States, MVP is prevalent in 7% of autopsies.[5]

Diagnosis

Signs and symptoms

While mitral valve prolapse has been associated with a variety of symptoms it should be noted that the frequency of these symptoms does not differ significantly from that of the general population. Therefore the causal link between mitral valve prolapse and these associated symptoms is not clear. Some patients with MVP experience heart palpitations, atrial fibrillation, or syncope. Between 11% and 15% of patients experience moderate chest pain and shortness of breath. These symptoms may not be directly attributable to the prolapsing mitral valve, but rather by the mitral regurgitation that often results from prolapse. In addition, the American Heart Association has linked anxiety and panic attack disorders to Mitral Valve Prolapse, although the causal nature of this association is not clear.

For unknown reasons, MVP patients tend to have a low body mass index (BMI) and are typically leaner than individuals without MVP.[4] MVP occurs more frequently among individuals with the Marfan syndrome.[6]

Auscultation

Upon auscultation a mid-systolic click is present, followed by a late systolic murmur which is best heard at the apex.

Echocardiography

2D Echo features

The leaflets and chordae are thick and reduntant. Reduced tensile strength leads to progressive elongation or rupture of chordae. Ruptured chordae appear as flail segments.

To diagnose mitral valve prolapse, the following criteria should be fulfilled - Movement of any part of either leaflet more than 2mm behind the annular plane in parasternal long axis view and movement of point of co-aptation behind the annular plane in apical 4 chamber view. Mitral regurgitation can result in enlarged LA size.

Doppler

Colour flow mapping and CW doppler shows predominantly late systolic mitral regurgitation.

M Mode Echocardiography

MItral Valve Prolapse.jpg M Mode

Left Ventriculography

{{#ev:googlevideo|1357398178641849422}}

Mitral valve prolapse syndrome

Mitral valve prolapse syndrome (MVP Syndrome), also referred to as mitral valve prolapse dysautonomia, is thought to represent an imbalance of the autonomic nervous system in association with mitral valve prolapse. The underlying etiology that causes both autonomic dysregulation and the structural abnormalities present in mitral valve prolapse is unknown. Most patients who suffer from mitral valve prolapse syndrome may have an underlying dysautonomia as the cause of their symptoms. In particular, supraventricular arrhythmias such as those observed with MVP syndrome are associated with increased parasympathetic tone.[7]

Symptoms generally attributed to MVP syndrome include palpitations, shortness of breath, and syncope. Because of the low specificity of these symptoms, and the fact that there is significant overlap in the causes of these symptoms with sequelae of significant mitral regurgitation often seen with mitral valve prolapse, MVP syndrome is most likely over-diagnosed.[8] The uncertainty regarding the frequency of this syndrome may in part be due to the fact that there is no consensus criteria to diagnose MVP syndrome.

Complications

Mitral regurgitation

Mitral valve prolapse is frequently associated with mild mitral regurgitation,[9] where blood aberrantly flows from the left ventricle into the left atrium during systole. Occasionally MVP patients experience severe regurgitation, often due to chordae tendineae rupture.[10]

Sudden death

Severe mitral valve prolapse is associated with arrhythmias and atrial fibrillation that may progress and lead to sudden death. As there is no evidence that a prolapsed valve itself contributes to such arrythmias,[8] these complications are more likely due to mitral regurgitation and congestive heart failure.

Prognosis

The major predictors of mortality are the severity of mitral regurgitation and the ejection fraction.[11] Generally, MVP is a benign disorder. However, MVP patients with a murmur, not just an isolated click, may have a poorer prognosis.[5]

Treatment

Most patients only need reassurance. Those with mitral valve prolapse and symptoms of dysautonomia (palpitations, chest pain) may often benefit from beta-blockers (e.g., propranolol). Patients with prior stroke and/or atrial fibrillation may require anticoagulation is, such as aspirin or warfarin.

Mitral valve prolapse associated with severe mitral regurgitation can be treated with repair or surgical replacement of the mitral valve. Repair of the mitral valve is always preferable to replacement and should be performed by surgeons that are skilled in the procedure. Current ACC/AHA guidelines suggest that early repair of mitral valve, performed in centers of surgical excellence, should be considered even in patients without symptoms of heart failure. Symptomatic patients, those with evidence of diminished left ventricular function or left ventricular dilatation need urgent attention.

Prevention of infective endocarditis

People with mitral valve prolapse are at higher risk of infective endocarditis (bacterial infection of the heart tissue), as a result of certain non-sterile procedures such as teeth cleaning and biopsy during colonoscopy. However, an April 2007 study by the American Heart Association has determined that the risks of prescribing antibiotics outweigh the benefits of antibiotic prophylaxis before an invasive procedure (such as dental surgery). Therefore, MVP patients who have taken prophylactic antibiotics routinely in the past may no longer need them.[12]

References

  1. Women's Heart Foundation, Inc. "Mitral Valve Prolapse". Retrieved 2007-07-11.
  2. Barlow JB, Bosman CK. (1966). "Aneurysmal protrusion of the posterior leaflet of the mitral valve. An auscultatory-electrocardiographic syndrome". Am Heart J. 71 (2): 166–78. PMID 4159172.
  3. Levy D, Savage D. (1987). "Prevalence and clinical features of mitral valve prolapse". Am Heart J. 113 (5): 1281–90. PMID 3554946.
  4. 4.0 4.1 Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ. (1999). "Prevalence and clinical outcome of mitral-valve prolapse". N Engl J Med. 341 (1): 1–7. PMID 10387935.
  5. 5.0 5.1 Mitral Valve Prolapse at eMedicine
  6. The National Marfan Foundation. "Related Disorders: Mitral Valve Prolapse". Retrieved 2007-07-11.
  7. Terechtchenko L, Doronina SA, Pochinok EM, Riftine A. (2003). "Autonomic tone in patients with supraventricular arrhythmia associated with mitral valve prolapse in young men". Pacing Clin Electrophysiol. 26 (1 Pt 2): 444–6. PMID 12687863.
  8. 8.0 8.1 Fogoros, Richard N. "Mitral Valve Prolapse (MVP)". Heart Disease. About.com. Retrieved 2007-07-11.
  9. Kolibash AJ (1988). "Progression of mitral regurgitation in patients with mitral valve prolapse". Herz. 13 (5): 309–17. PMID 3053383.
  10. Tanser, Paul H. (March 2007). "Mitral Valve Prolapse (MVP)". Merck. Retrieved 2007-07-11.
  11. Rodgers, Ellie (May 11, 2004). "Mitral Valve Regurgitation". Healthwise, on Yahoo. Retrieved 2007-07-11.
  12. Wilson W, Taubert KA, Gewitz M; et al. (2007). "Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group" (PDF). Journal of the American Dental Association. 138 (6): 739–45, 747–60. PMID 17545263.

External links

Template:SIB

ca:Prolapse mitral de:MitralklappenprolapsTemplate:Link FA fa:افتادگی دریچه میترال he:צניחה של השסתום המיטרלי


Template:WikiDoc Sources